Description
多年来，科学家们一直在探索治愈失明的技术。最近，光遗传学领域的最新进展，让一位患者时隔40年后看见复明的希望。法国生物制药公司GenSight联合多国科研人员，利用的是光遗传学这一新兴技术，也就是将“感光基因”（optogene）转入视网膜中特定类型的细胞里，帮助失明人士逐步恢复视觉能力。目前，这一疗法仍有待进一步完善。由于只导入了一种对特定波长的光敏感的感光基因，所以患者还不能恢复彩色视觉，不过未来或许可以将多种不同的感光基因组合来实现这一点。
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast